-
Cerulean Pharma Inc (NASDAQ: CERU) shares jumped
36.8 percent to $2.08. Cerulean Pharma shares have dropped 33.91 percent over the past 52 weeks, while the S&P 500 index
has gained 17.48 percent in the same period.
-
Mobileye NV (NYSE: MBLY) shares surged 29.6 percent
to $61.27. Intel Corporation (NASDAQ: INTC)
announced plans to acquire Mobileye for $15.3 billion, or $63.54 per share in cash.
-
Verastem Inc (NASDAQ: VSTM) shares gained 19.4
percent to $1.48.
-
Heat Biologics Inc (NASDAQ: HTBX) shares climbed
16.7 percent to $1.05 after the company disclosed that it has achieved the efficacy endpoint in its Phase 1b trial.
-
AMEC Foster Wheeler plc (NYSE: AMFW) shares jumped
14.2 percent to $6.74 after Wood Group announced plans to acquire Amec in a $2.73 billion deal.
-
Pulse Biosciences Inc (NASDAQ: PLSE) shares
jumped 13.8 percent to $20.73.
-
NL Industries Inc (NYSE: NL) shares gained 13.7
percent to $6.65. NL Industries posted Q4 earnings of $0.20 per share on revenue of $26.3 million.
-
Valhi, Inc. (NYSE: VHI) climbed 11.6 percent to
$3.47. Valhi reported Q4 net income of $9.1 million on revenue of $407.9 million.
-
Geopark Ltd (NYSE: GPRK) rose 10.5 percent to
$6.75. JP Morgan upgraded Geopark from Neutral to Overweight.
-
Scorpio Bulkers Inc (NYSE: SALT) surged 9.2 percent
to $8.35. Credit Suisse upgraded Scorpio Bulkers from Neutral to Outperform.
-
Mechel PAO (ADR) (NYSE: MTL) rose 9 percent to
$4.75. Mechel announced the launch of a new longwall at Southern Kuzbass.
-
Lifetime Brands Inc (NASDAQ: LCUT) shares climbed
8.7 percent to $15.70 after the company reported strong earnings for its fourth quarter.
-
Kirkland's, Inc. (NASDAQ: KIRK) gained 8.2
percent to $12.41. Raymond James upgraded Finisar from Outperform to Strong Buy.
-
Central Federal Corporation (NASDAQ: CFBK) shares
rose 7.1 percent to $2.09 after gaining 1.56 percent on Friday.
-
Cempra Inc (NASDAQ: CEMP) shares rose 4 percent
to $3.74. Cempra retained Morgan Stanley to lead its process to review strategic business options.
-
Blueprint Medicines Corp (NASDAQ: BPMC) gained
3.3 percent to $40.61. Goldman Sachs upgraded Blueprint Medicines from Neutral to Buy.
-
Gartner Inc (NYSE: IT) rose 3 percent to $108.92. RBC
Capital upgraded Gartner from Outperform to Top Pick and raised the price target from $117.00 to $124.00.
-
Health Insurance Innovations Inc (NASDAQ: HIIQ)
shares rose 3 percent to $16.20. Canaccord Genuity initiated coverage on Health Insurance with a Buy rating.
Latest Ratings for CERU
Date |
Firm |
Action |
From |
To |
Aug 2016 |
Barclays |
Maintains |
|
Overweight |
Aug 2016 |
Wedbush |
Downgrades |
Outperform |
Neutral |
Aug 2016 |
Leerink Swann |
Downgrades |
Outperform |
Market Perform |
View More Analyst Ratings for
CERU
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.